Amyris announces $50M common stock offering and private placement
Synthetic biotechnology company Amyris, Inc. (NASDAQ:AMRS) announced Thursday a registered direct of
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial